Aluminum

erythropoietin ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23343454 Aluminum in erythropoietin formulations: lyophilized versus liquid forms. 2013 8
2 22174104 Oxidative stress due to aluminum exposure induces eryptosis which is prevented by erythropoietin. 2012 May 5
3 21983256 Evidence for aluminum-binding erythropoietin by size-exclusion chromatography coupled to electrothermal absorption atomic spectrometry. 2011 Nov 7
4 22371781 Aluminium and lead abnormalities in children on haemodialysis: relationship with some medications. 2010 Jun 30 1
5 15777837 The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor. 2005 Mar 22 6
6 15829127 In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring. 2005 Mar 1
7 12091599 Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia? 2002 1
8 11590253 Hyporesponsiveness to recombinant human erythropoietin. 2001 1
9 9915269 Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. 1999 Jan 1
10 9481432 Recombinant human erythropoietin resistance in iron-replete hemodialysis patients: role of aluminum toxicity. 1998 1
11 9689168 Effect of serum parathyroid hormone and aluminum levels on the response to erythropoietin in uremia. 1998 Aug 1
12 9159297 A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease. 1997 May 2
13 9263684 Adynamic bone disease: pathogenesis, diagnosis and clinical relevance. 1997 Jul 1
14 9156931 [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin]. 1996 Oct 1
15 7731142 Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication. 1995 Jan 1
16 8080342 Case study of the anemic patient: epoetin alfa--focus on CQI and patient management. 1994 Aug 1
17 8289992 Effects of erythropoietin on trace elements in patients with chronic renal failure undergoing hemodialysis. 1993 1
18 8506193 Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy. 1993 Feb 3
19 1328942 Aluminium overload and response to recombinant human erythropoietin in patients under chronic haemodialysis. 1992 1
20 1775251 Aluminium content of water for injection used with recombinant human erythropoietin. 1991 2
21 1865507 Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. 1991 Mar 2
22 1870750 The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients. 1991 1
23 2003757 Case management of the anemic patient epoetin alfa: focus on aluminum management. 1991 Feb 1
24 1967718 Erythropoietin, aluminium, and anaemia in patients on haemodialysis. 1990 Feb 3 2
25 2091687 Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism. 1990 1
26 2093544 Aluminium interference in the treatment with recombinant human erythropoietin. 1990 1
27 2113221 Aluminium intoxication in the rat induces partial resistance to the effect of recombinant human erythropoietin. 1990 1
28 2122321 Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin. 1990 1
29 2239943 The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment. 1990 Nov 3
30 2331725 [Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?]. 1990 Jan 26 1
31 2684530 Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin. 1989 1
32 2809506 Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis. 1989 Nov 1